Surviving Pneumonia
NCT03795662 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2021-04-29
Summary
The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.
Conditions
- Community-acquired Pneumonia
Interventions
- OTHER
-
No intervention
Obervational
Sponsors & Collaborators
-
Nordsjaellands Hospital
lead OTHER
Principal Investigators
-
Birgitte Lindegaard, Assoc. Prof · Nordsjaellands Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-07
- Primary Completion
- 2023-12-31
- Completion
- 2038-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
A Global Active Surveillance for Community Acquired Pneumonia
NCT00929721 ·Status: COMPLETED ·Phase: NA
-
Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity Score
NCT04135183 ·Status: UNKNOWN ·Phase: NA
-
The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)
NCT06295120 ·Status: RECRUITING ·Phase: PHASE4
-
Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia
NCT04089787 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals
NCT02224716 ·Status: UNKNOWN
-
Epidemiological Study on Community Acquired Pneumonia
NCT02139163 ·Status: RECRUITING
-
Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia
NCT05903352 ·Status: RECRUITING ·Phase: PHASE3
-
Costs, Health Status and Outcomes of CAP (Community-Acquired Pneumonia)
NCT00812084 ·Status: COMPLETED
-
Community-Acquired Pneumonia (CAP) Surveillance
NCT01416506 ·Status: COMPLETED
-
Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia
NCT02276092 ·Status: COMPLETED
-
Antibiotic Therapy In Respiratory Tract Infections
NCT04166110 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Procalcitonin as a Marker of Bacterial Pneumonia
NCT00415753 ·Status: COMPLETED ·Phase: NA
-
Failure and Cardiovascular Events in Community-acquired Pneumonia
NCT01143155 ·Status: COMPLETED
-
Characteristics of Hospitalized Patients With Community-acquired Pneumonia
NCT06065618 ·Status: RECRUITING
-
Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia
NCT04652167 ·Status: COMPLETED
-
Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia
NCT00273676 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression
NCT05688774 ·Status: RECRUITING
-
Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status
NCT02141009 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers for Ventilator-associated Pneumonia
NCT05117125 ·Status: RECRUITING
-
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
NCT01964495 ·Status: COMPLETED ·Phase: NA
-
Community-Acquired Pneumonia : Evaluation of Corticosteroids
NCT02517489 ·Status: COMPLETED ·Phase: PHASE3
-
Improved Use of Antibiotic Guidelines in Hospital Environment
NCT00512772 ·Status: COMPLETED
-
HCAPPED I: HCAP-Pcr in Emergency Department
NCT06506617 ·Status: RECRUITING
-
A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia
NCT02963142 ·Status: COMPLETED
-
Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia
NCT03452826 ·Status: COMPLETED ·Phase: NA